Target intelligence / Profile preview

Tear film lipid and mucin layers

Molecular classification
Biological structure, Lipid, Mucin, Glycoprotein, Other
01

Overview

The tear film lipid and mucin layers are integral components of the precorneal tear film, essential for maintaining ocular surface homeostasis and optical quality. The lipid layer, primarily produced by the Meibomian glands, forms the outermost interface to prevent tear evaporation and provide structural stability (TFOS DEWS II, 2017). The mucin layer, consisting of glycoproteins like MUC5AC secreted by conjunctival goblet cells, acts as a surfactant to spread the aqueous layer over the hydrophobic corneal epithelium (StatPearls, 2023). Deficiencies in these layers are central to the pathogenesis of dry eye disease, leading to tear film instability and ocular surface damage. Pharmacological targeting involves lipid-replenishing drops, such as perfluorohexyloctane, or mucin secretagogues like rebamipide and diquafosol (PubMed, 2021). These therapies aim to restore the protective barrier and improve patient symptoms of irritation and blurred vision.

Other names
Precorneal tear filmOcular surface filmTear filmLipid-mucin complexTear film lipid layerTear film mucin layer
02

Mechanism of action

Therapeutic agents target these layers by supplementing deficient lipids to reduce evaporation, stimulating goblet cells to increase mucin secretion, or providing mucoadhesive polymers to stabilize the tear film structure (TFOS DEWS II, 2017).

03

Biological functions

LubricationOcular surface protectionRefractive surface maintenanceEvaporation preventionHydrationOther
04

Disease associations

Dry eye diseaseMeibomian gland dysfunctionKeratoconjunctivitis siccaSjögren's syndromeInflammationOther
05

Safety considerations

Transient blurred visionOcular irritationPreservative-induced toxicityAllergic conjunctivitis
06

Interacting drugs

Perfluorohexyloctane

5 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Tear osmolarityLipid layer thickness (LLT)Schirmer test scoreOcular Surface Disease Index (OSDI)

Beyond the preview

Go deeper on Tear film lipid and mucin layers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear film lipid and mucin layers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call